Sign in
4

Changes in Ownership

BriaCell Therapeutics Corp. Filed Acc 0001493152-22-036643

Options or other derivatives

  • President, CEO bought 2,530 shares at $1.94 ($4,908)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Williams William V. President, CEO 2022-12-23 Purchase · Warrant +2,530 $1.94 $4,908 29,802 D: show line 1 in the form
Loading xslF345X03/ownership.xml…